In continuation to its history of mergers and acquisitions, M/s AGP Limited in conjunction with its parent company M/s Aitkenstuart has setup an entity to acquire SANDOZ and big brands like AZOMAX, ZATOFEN, and AMOXI-CLAV. These brands shall be acquired using optimal capital structure with an equity and debt ratio of 30:70, the 65% stakes of which shall be held by the entity which has been jointly setup as Special Purpose Vehicle.
The company’s revenue and profitability is expected to cross three billion mark in less than a years’ time.
AGP hit the year 2020 with a growth trajectory and surpassed the challenges of COVID led uncertainty and volatility and has started making headlines in the 1QCY2021 with mergers, acquisitions and making space into GoP’s five months vaccine plan.
Supply of five million with a likelihood of margin of around 2 dollar per dose, and recent acquisition deal for one of the division of NOVARTIS would also entail margin @ 25-30% margins, Market Analysts Says